Skip to menu Skip to content Skip to footer

2011

Journal Article

Bayesian optimisation of tobramycin dosing in paediatric patients with cystic fibrosis

Barras, Michael, Alraman, Hana, Kirkpatrick, Carl M. J., Harris, Margaret, Dakin, Carolyn, Jess, Katrina, Pilbeam, Melissa and Norris, Ross L. G. (2011). Bayesian optimisation of tobramycin dosing in paediatric patients with cystic fibrosis. Journal of Pharmacy Practice and Research, 41 (3), 183-187. doi: 10.1002/j.2055-2335.2011.tb00857.x

Bayesian optimisation of tobramycin dosing in paediatric patients with cystic fibrosis

2010

Journal Article

Current status of therapeutic drug monitoring in Australia and New Zealand: A need for improved assay evaluation, best practice guidelines, and professional development

Norris, Ross L., Martin, Jennifer H., Thompson, Erin, Ray, John E., Fullinfaw, Robert O., Joyce, David, Barras, Michael, Jones, Graham R. and Morris, Raymond G. (2010). Current status of therapeutic drug monitoring in Australia and New Zealand: A need for improved assay evaluation, best practice guidelines, and professional development. Therapeutic Drug Monitoring, 32 (5), 615-623. doi: 10.1097/FTD.0b013e3181ea3e8a

Current status of therapeutic drug monitoring in Australia and New Zealand: A need for improved assay evaluation, best practice guidelines, and professional development

2010

Journal Article

Individualized dosing of enoxaparin for subjects with renal impairment is superior to conventional dosing at achieving therapeutic concentrations

Barras, Michael A., Duffull, Stephen B., Atherton, John J. and Green, Bruce (2010). Individualized dosing of enoxaparin for subjects with renal impairment is superior to conventional dosing at achieving therapeutic concentrations. Therapeutic Drug Monitoring, 32 (4), 482-488. doi: 10.1097/FTD.0b013e3181e64846

Individualized dosing of enoxaparin for subjects with renal impairment is superior to conventional dosing at achieving therapeutic concentrations

2010

Journal Article

Current dosing of low-molecular-weight heparins does not reflect licensed product labels: An international survey

Barras, Michael A., Kirkpatrick, Carl M.J. and Green, Bruce (2010). Current dosing of low-molecular-weight heparins does not reflect licensed product labels: An international survey. British Journal of Clinical Pharmacology, 69 (5), 520-528. doi: 10.1111/j.1365-2125.2010.03626.x

Current dosing of low-molecular-weight heparins does not reflect licensed product labels: An international survey

2010

Journal Article

Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

Martin, Jennifer H., Norris, Ross, Barras, Michael, Roberts, Jason, Morris, Ray, Doogue, Matthew and Jones, Graham R. D. (2010). Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Clinical Biochemist Reviews, 31 (1), 21-24.

Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

2010

Journal Article

Routine plasma anti-Xa monitoring is required for low-molecular-weight heparins

Al-Sallami, Hesham S., Barras, Michael A., Green, Bruce and Duffull, Stephen B. (2010). Routine plasma anti-Xa monitoring is required for low-molecular-weight heparins. Clinical Pharmacokinetics, 49 (9), 567-571. doi: 10.2165/11532960-000000000-00000

Routine plasma anti-Xa monitoring is required for low-molecular-weight heparins

2009

Journal Article

Modelling the occurrence and severity of enoxaparin-induced bleeding and bruising events

Barras, M. A., Duffull, S. B., Atherton, J. J. and Green, B. (2009). Modelling the occurrence and severity of enoxaparin-induced bleeding and bruising events. British Journal of Clinical Pharmacology, 68 (5), 700-711. doi: 10.1111/j.1365-2125.2009.03518.x

Modelling the occurrence and severity of enoxaparin-induced bleeding and bruising events

2009

Journal Article

Myalgia in patients on high-dose and low-to-moderate dose statin therapy

Gujral, Gina R., Cottrell, W. Neil and Barras, Michael (2009). Myalgia in patients on high-dose and low-to-moderate dose statin therapy. Journal of Pharmacy Practice and Research, 39 (3), 202-206. doi: 10.1002/j.2055-2335.2009.tb00453.x

Myalgia in patients on high-dose and low-to-moderate dose statin therapy

2009

Journal Article

Preliminary results of a therapeutic drug monitoring survey in Australasia

Norris, R. L., Morris, R. G., Ray, J. E., Fullinfaw, R. O., Ilett, K. F., Lee, T., Martin, J., Barras, M., Thompson, E. M. and Jones, G. R. D. (2009). Preliminary results of a therapeutic drug monitoring survey in Australasia. Pathology, 41 (s1), 71-71. doi: 10.1097/01268031-200941001-00167

Preliminary results of a therapeutic drug monitoring survey in Australasia

2008

Journal Article

Individualized compared with conventional dosing of enoxaparin

Barras, M. A., Duffull, S. B., Atherton, J. J. and Green, B. (2008). Individualized compared with conventional dosing of enoxaparin. Clinical Pharmacology & Therapeutics, 83 (6), 882-888. doi: 10.1038/sj.clpt.6100399

Individualized compared with conventional dosing of enoxaparin

2008

Journal Article

Individualised vs conventional enoxaparin dosing

Barras, Michael A. and Green, Bruce (2008). Individualised vs conventional enoxaparin dosing. Journal of Pharmacy Practice and Research, 38 (1), 77-81. doi: 10.1002/j.2055-2335.2008.tb00803.x

Individualised vs conventional enoxaparin dosing

2007

Journal Article

Maximal torque- and power-pedaling rate relationships for elite sprint cyclists in laboratory and field tests

Gardner, A. Scott, Martin, James C., Martin, David T., Barras, Martin and Jenkins, 47517 (2007). Maximal torque- and power-pedaling rate relationships for elite sprint cyclists in laboratory and field tests. European Journal of Applied Physiology, 101 (3), 287-292. doi: 10.1007/s00421-007-0498-4

Maximal torque- and power-pedaling rate relationships for elite sprint cyclists in laboratory and field tests

2007

Journal Article

General practitioner referral letters: are we getting the full picture?

Toleman, J. and Barras, M. (2007). General practitioner referral letters: are we getting the full picture?. Internal Medicine Journal, 37 (7), 510-511. doi: 10.1111/j.1445-5994.2007.01416.x

General practitioner referral letters: are we getting the full picture?

2007

Journal Article

Pharmacists investigating adverse penicillin responses - Pilot Study

Roberts, Jason A., Hsu, Millie, Allen, Karen, Willis, Jennifer and Barras, Michael (2007). Pharmacists investigating adverse penicillin responses - Pilot Study. Journal of Pharmacy Practice and Research, 37 (3), 200-203. doi: 10.1002/j.2055-2335.2007.tb00744.x

Pharmacists investigating adverse penicillin responses - Pilot Study

2006

Journal Article

Are patients on long-term corticosteroids receiving bone loss therapy?

Rofail, Serena and Barras, Michael A. (2006). Are patients on long-term corticosteroids receiving bone loss therapy?. Journal of Pharmacy Practice and Research, 36 (1), 29-31. doi: 10.1002/j.2055-2335.2006.tb00882.x

Are patients on long-term corticosteroids receiving bone loss therapy?

2005

Journal Article

Patients' understanding of drug allergy and documentation: Is there a link?

Sim, Lily, Barras, Michael and Cottrell, Neil (2005). Patients' understanding of drug allergy and documentation: Is there a link?. Journal of Pharmacy Practice and Research, 35 (4), 276-278. doi: 10.1002/j.2055-2335.2005.tb00362.x

Patients' understanding of drug allergy and documentation: Is there a link?

2005

Journal Article

Teaching people with Parkinson's disease about their medication

O'Maley, Karen, O'Sullivan, John, Wollin, Judy, Barras, Michael and Brammer, Jillian (2005). Teaching people with Parkinson's disease about their medication. Nursing Older People, 17 (1) doi: 10.7748/nop2005.03.17.1.14.c2357

Teaching people with Parkinson's disease about their medication

2004

Journal Article

Effective conference presentations

Lum, E. and Barras, M.A. (2004). Effective conference presentations. Journal of Pharmacy Practice and Research, 34 (2), 157-158.

Effective conference presentations